Ranbaxy's Renewed India Focus
  • Prabha Hedge
  • Jan 02 2014

January 2: The run-ins with the U.S. FDA is making Ranbaxy shift its focus back to India. Mint reports that company is increasing its India sales target to Rs.13,500 crore for 15 months ending March 2014. Mint’s C.H. Unnikrishnan shares a detailed report.